Pharmacokinetics, safety, and effects on exercise performance of l-arginine α-ketoglutarate in trained adult men

Nutrition

Volumn 22, Issue 9, 2006, Pages 872-881

  Campbell, Bill ^a   Roberts, Mike ^a   Kerksick, Chad ^a   Wilborn, Colin ^a   Marcello, Brandon ^a   Taylor, Lem ^a   Nassar, Erika ^a   Leutholtz, Brian ^a   Bowden, Rodney ^a   Rasmussen, Chris ^a   Greenwood, Mike ^a   Kreider, Richard ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Ergogenic aid; Exercise; Resistance training; Sports nutrition; Supplementation

Indexed keywords

2 OXOGLUTARIC ACID; ARGININE; ARGININE ALPHA KETOGLUTARATE; BIOLOGICAL MARKER; GLUCOSE; UNCLASSIFIED DRUG;

ADULT; AEROBIC CAPACITY; ANAEROBIC EXERCISE; ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MUSCLE EXERCISE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMETRY; QUADRICEPS FEMORIS MUSCLE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TOTAL BODY WATER; TRAINING;

ADULT; ANAEROBIC THRESHOLD; ANALYSIS OF VARIANCE; ARGININE; BODY COMPOSITION; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXERCISE; HUMANS; KETOGLUTARIC ACIDS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; SAFETY; WEIGHT LIFTING;

EID: 33747428370     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2006.06.003     Document Type: Article

References (49)

1. Wu G., and Morris Jr. S.M. Arginine metabolism. nitric oxide and beyond. Biochem J 336 pt 1 (1998) 1-17
2. In: Hendler S.S., and Rorvik D. (Eds). PDR for nutritional supplements. 1st ed. (2001), PDR Thompson, Montvale, NJ
3. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
4. Boger R.H., and Bode-Boger S.M. The clinical pharmacology of l-arginine. Annu Rev Pharmacol Toxicol 41 (2001) 79-99
5. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., et al. Mitochondrial biogenesis in mammals. the role of endogenous nitric oxide. Science 299 5608 (2003) 896-899
6. Lind D.S. Arginine and cancer. J Nutr 134 suppl (2004) 2837S-41
7. Kobzik L., Reid M.B., and Bredt DS Stamler J.S. Nitric oxide in skeletal muscle. Nature 372 6506 (1994) 546-548
8. Reid M.B. Role of nitric oxide in skeletal muscle. synthesis, distribution and functional importance. Acta Physiol Scand 162 (1998) 401-409
9. Vallance P., and Leiper J. Blocking NO synthesis. how, where and why?. Nat Rev Drug Discov 1 (2002) 939-950
10. Nakaki T., and Hishikawa K. [The arginine paradox]. Nippon Yakurigaku Zasshi 119 (2002) 7-14
11. Preli R.B., Klein K.P., and Herrington D.M. Vascular effects of dietary l-arginine supplementation. Atherosclerosis 162 (2002) 1-15
12. Barbul A. Arginine. biochemistry, physiology, and therapeutic implications. JPEN 10 (1986) 227-238
13. Tong B.C., and Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem 4 (2004) 823-832
14. Joyner M.J. Glutamine and arginine. immunonutrients and metabolic modulators?. Exerc Sport Sci Rev 33 (2005) 105-106
15. Paddon-Jones D., Borsheim E., and Wolfe R.R. Potential ergogenic effects of arginine and creatine supplementation. J Nutr 134 suppl (2004) 2888S-94
16. Hammarqvist F., Wernerman J., von der Decken A., and Vinnars E. Alpha-ketoglutarate preserves protein synthesis and free glutamine in skeletal muscle after surgery. Surgery 109 (1991) 28-36
17. Le Boucher J., Obled C., Farges M.C., and Cynober L. Ornithine alpha-ketoglutarate modulates tissue protein metabolism in burn-injured rats. Am J Physiol 273 pt 1 (1997) E557-E563
18. Le Bricon T., Cynober L., and Baracos V.E. Ornithine alpha-ketoglutarate limits muscle protein breakdown without stimulating tumor growth in rats bearing Yoshida ascites hepatoma. Metabolism 43 (1994) 899-905
19. Czernichow B., Nsi-Emvo E., Galluser M., Gosse F., and Raul F. Enteral supplementation with ornithine alpha ketoglutarate improves the early adaptive response to resection. Gut 40 (1997) 67-72
20. Wiren M., Permert J., and Larsson J. Alpha-ketoglutarate-supplemented enteral nutrition. effects on postoperative nitrogen balance and muscle catabolism. Nutrition 18 (2002) 725-728
21. Cynober L.A. Goodbye sodium alpha-ketoglutarate?. Nutrition 18 (2002) 772-773
22. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
23. McNair D., Lorr M., and Droppleman L. Edits manual for the profile of mood states (1992), Educational and Industrial Testing Service, San Diego
24. Richter P., Werner J., Heerlein A., Kraus A., and Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 31 (1998) 160-168
25. I, occupational stress inventory (1998), Psychological Assessment Resources, Lutz, FL
26. In: Baechle T., and Earle R. (Eds). Essentials of strength training and conditioning. 2nd ed. (2000), Human Kinetics, Champaign, IL
27. Hargreaves K.M., and Pardridge W.M. Neutral amino acid transport at the human blood-brain barrier. J Biol Chem 263 (1988) 19392-19397
28. ACSM's guidelines for exercise testing and prescription. 6th ed. (2000), Lippincott Williams & Wilkins, Philadelphia
29. Van Loan M.D. Bioelectrical impedance analysis to determine fat-free mass, total body water and body fat. Sports Med 10 (1990) 205-217
30. Diagnostic and therapeutic technology assessment. Measurement of bone density with dual-energy X-ray absorptiometry (DEXA). JAMA 267 (1992) 286-288 290-4
31. Klesges R.C., Ward K.D., Shelton M.L., Applegate W.B., Cantler E.D., Palmieri G.M., et al. Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects. JAMA 276 (1996) 226-230
32. Song Y., Quan Z., Evans J.L., Byrd E.A., and Liu Y.M. Enhancing capillary liquid chromatography/tandem mass spectrometry of biogenic amines by pre-column derivatization with 7-fluoro-4-nitrobenzoxadiazole. Rapid Commun Mass Spectrom 18 (2004) 989-994
33. Kawabata Y., Senda M., Oka T., Yagata Y., Takahara Y., and Nagashima H Inoue H. Measurement of fatigue in knee flexor and extensor muscles. Acta Med Okayama 54 (2000) 85-90
34. Pincivero D.M., Gear W.S., and Sterner R.L. Assessment of the reliability of high-intensity quadriceps femoris muscle fatigue. Med Sci Sports Exerc 33 (2001) 334-338
35. Fielding R.A., Frontera W.R., Hughes V.A., Fisher E.C., and Evans W.J. The reproducibility of the Bruce protocol exercise test for the determination of aerobic capacity in older women. Med Sci Sports Exerc 29 (1997) 1109-1113
36. Brazier J.E., Harper R., Jones N.M., O'Cathain A., Thomas K.J., Usherwood T., and Westlake L. Validating the SF-36 health survey questionnaire. new outcome measure for primary care. BMJ 305 6846 (1992) 160-164
37. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
38. Walberg-Rankin J., Hawkins C., Fild D., and Sebolt D. The effect of oral arginine during energy restriction in male weight trainers. J Strength Cond Res 8 (1994) 170-177
39. Santos R.S., Pacheco M.T.T., Martins R.A.B.L., Villaverde A.B., Giana H.E., Baptista F., and Zangaro R.A. Study of the effect of oral administration of l-arginine on muscular performance in healthy volunteers. an isokinetic study. Isokinet Exerc Sci 10 (2002) 153-158
40. Buford B.N., and Koch A.J. Glycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Med Sci Sports Exerc 36 (2004) 583-587
41. Persky A.M., and Brazeau G.A. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 53 (2001) 161-176
42. Hultman E., Soderlund K., Timmons J.A., Cederblad G., and Greenhaff P.L. Muscle creatine loading in men. J Appl Physiol 81 (1996) 232-237
43. Earnest C.P., Snell P.G., Rodriguez R., Almada A.L., and Mitchell T.L. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 153 (1995) 207-209
44. Tarnopolsky M.A., and MacLennan D.P. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab 10 (2000) 452-463
45. Bednarz B., Jaxa-Chamiec T., Gebalska J., Herbaczynska-Cedro K., and Ceremuzynski L. l-arginine supplementation prolongs duration of exercise in congestive heart failure. Pol Heart J 60 (2004) 348-353
46. Ceremuzynski L., Chamiec T., and Herbaczynska-Cedro K. Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 80 (1997) 331-333
47. Mizuno T., Watanabe M., Sakamoto T., and Sunamori M. l-arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate. J Thorac Cardiovasc Surg 115 (1998) 931-936
48. Nagaya N., Uematsu M., Oya H., Sato N., Sakamaki F., Kyotani S., et al. Short-term oral administration of l-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 163 (2001) 887-891
49. Siani A., Pagano E., Iacone R., Iacoviello L., Scopacasa F., and Strazzullo P. Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am J Hypertens 13 pt 1 (2000) 547-551